• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Future of imaging science depends on risk takers

Article

Radiologists need to become great risk takers and follow clinical science's move toward systems biology or become irrelevant, according to Dr. Elias Zerhouni, director of the National Institutes of Health.

Radiologists need to become great risk takers and follow clinical science's move toward systems biology or become irrelevant, according to Dr. Elias Zerhouni, director of the National Institutes of Health.

Imagers need to replace the current imaging approach to understand complex disease mechanisms, such as inflammation or apoptosis, rather than simply specific conditions, like arthritis or cancer. That means moving down the angstrom scale to resolve complex macromolecular structures, Zerhouni said.

Radiologists should develop biomarkers to assist in the study of treatments for long-term chronic diseases and get involved in image-guided intervention and microsampling for disease characterization, he said.

Zerhouni spoke during a session on the future of biomedical imaging and imaging research at the European Congress of Radiology. The NIH will invest about $1 billion in 2007 in projects with non-U.S. partners.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.